With the card, Ozempic costs $499 a month for established patients who take 2 mg
The rising prevalence of diabetes and obesity, particularly in China, India, and Japan, is fueling demand for GLP-1 therapies
Hematopoietic retroviral gene marking in patients with follicular non-Hodgkin's lymphoma
If you have minimal fat to lose, non-invasive options might be sufficient
A 2025 study evaluating the short-term management of obesity found that subcutaneous Tirzepatide was cost-effective compared to both subcutaneous and oral semaglutide, with an incremental cost-effectiveness ratio (ICER) of $34,212 per quality-adjusted life-year (QALY) gained versus oral semaglutide, well below the common willingness-to-pay threshold of $150,000/QALY
In contrast, chemotherapy is often associated with alopecia , neutropenia , nausea , fatigue , and mucositis , which can significantly impact quality of life